TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,290.00
-980.00 (-29.97%)
Aug 29, 2025, 9:40 AM KST

TELCON RF PHARMACEUTICAL. Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Operating Revenue
41,01637,86536,30727,83037,84133,141
Upgrade
Other Revenue
0--0--0-
Upgrade
41,01637,86536,30727,83037,84133,141
Upgrade
Revenue Growth (YoY)
6.16%4.29%30.46%-26.46%14.18%-41.44%
Upgrade
Cost of Revenue
30,90727,62826,80022,26728,78025,905
Upgrade
Gross Profit
10,10910,2379,5075,5639,0617,236
Upgrade
Selling, General & Admin
6,2036,2524,4844,5546,9497,391
Upgrade
Research & Development
731.84722.94733.171,2081,6351,817
Upgrade
Other Operating Expenses
228.39112.5459.7668.03168.353.62
Upgrade
Operating Expenses
10,11010,3078,5429,62613,6249,326
Upgrade
Operating Income
-1.75-70.55965.32-4,063-4,563-2,090
Upgrade
Interest Expense
-5,520-3,760-603.58-1,063-7,702-2,849
Upgrade
Interest & Investment Income
481.57324.97205.0561.4245.4857.21
Upgrade
Earnings From Equity Investments
-18,358-24,684469.53-17,868-13,196-39,204
Upgrade
Currency Exchange Gain (Loss)
-49.75602.71119.08318.02831.71178.36
Upgrade
Other Non Operating Income (Expenses)
-6,1331,119-837.92-1,98177.32-135.85
Upgrade
EBT Excluding Unusual Items
-29,581-26,468317.48-24,595-24,507-44,042
Upgrade
Impairment of Goodwill
------4,179
Upgrade
Gain (Loss) on Sale of Investments
5,5321,27513,466-13,1464,6269,010
Upgrade
Gain (Loss) on Sale of Assets
-0.0517.27-14.834.3810.31-179.33
Upgrade
Asset Writedown
-1,125-1,097-64.8-4,411-3,005-51.13
Upgrade
Other Unusual Items
-434.02-227.31244.63---2,209
Upgrade
Pretax Income
-25,608-26,50013,949-42,117-22,875-41,652
Upgrade
Income Tax Expense
-----18.95
Upgrade
Earnings From Continuing Operations
-25,608-26,50013,949-42,117-22,875-41,671
Upgrade
Earnings From Discontinued Operations
-----331.42-355.73
Upgrade
Net Income to Company
-25,608-26,50013,949-42,117-23,207-42,027
Upgrade
Minority Interest in Earnings
6.07180.11-42.3432.81108.81,134
Upgrade
Net Income
-25,602-26,32013,906-42,084-23,098-40,893
Upgrade
Net Income to Common
-25,602-26,32013,906-42,084-23,098-40,893
Upgrade
Shares Outstanding (Basic)
363534322626
Upgrade
Shares Outstanding (Diluted)
363545412626
Upgrade
Shares Change (YoY)
5.06%-20.89%8.89%56.33%2.65%3.29%
Upgrade
EPS (Basic)
-709.92-741.54414.65-1322.39-876.43-1592.68
Upgrade
EPS (Diluted)
-710.15-741.67341.71-1322.39-876.43-1593.85
Upgrade
Free Cash Flow
-3,930-3,749-4,954-2,912-2,6131,671
Upgrade
Free Cash Flow Per Share
-108.98-105.63-110.43-70.69-99.1365.08
Upgrade
Gross Margin
24.64%27.03%26.19%19.99%23.95%21.83%
Upgrade
Operating Margin
-0.00%-0.19%2.66%-14.60%-12.06%-6.31%
Upgrade
Profit Margin
-62.42%-69.51%38.30%-151.22%-61.04%-123.39%
Upgrade
Free Cash Flow Margin
-9.58%-9.90%-13.64%-10.46%-6.90%5.04%
Upgrade
EBITDA
4,5614,4365,210218.47-363.072,307
Upgrade
EBITDA Margin
11.12%11.72%14.35%0.78%-0.96%6.96%
Upgrade
D&A For EBITDA
4,5624,5074,2444,2814,2004,397
Upgrade
EBIT
-1.75-70.55965.32-4,063-4,563-2,090
Upgrade
EBIT Margin
-0.00%-0.19%2.66%-14.60%-12.06%-6.31%
Upgrade
Advertising Expenses
-35.0610.7745.183.3618.62
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.